feedburner

Enter your email address:

Delivered by FeedBurner

Zydus Cadila gets USFDA nod to market generic cancer drug

The company has received final approval from the US Food and Drug
Administration (USFDA) to market its product which is a generic
version of Gleevec tablets, Zydus Cadila said in a statement.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-generic-cancer-drug/articleshow/75061780.cms



0 comments:

Post a Comment